370 related articles for article (PubMed ID: 28131850)
1. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM
Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850
[TBL] [Abstract][Full Text] [Related]
2. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
[TBL] [Abstract][Full Text] [Related]
3. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
4. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
5. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
[TBL] [Abstract][Full Text] [Related]
6. Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?
Singh A; Bharati A; Frederiks P; Verkinderen O; Goderis B; Cardinaels R; Moldenaers P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2016 Jun; 13(6):1879-93. PubMed ID: 27092396
[TBL] [Abstract][Full Text] [Related]
7. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
8. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT
J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
[TBL] [Abstract][Full Text] [Related]
9. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
10. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.
Karashima M; Sano N; Yamamoto S; Arai Y; Yamamoto K; Amano N; Ikeda Y
Eur J Pharm Biopharm; 2017 Jun; 115():65-72. PubMed ID: 28223260
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
Thiry J; Broze G; Pestieau A; Tatton AS; Baumans F; Damblon C; Krier F; Evrard B
Eur J Pharm Sci; 2016 Mar; 85():94-105. PubMed ID: 26850682
[TBL] [Abstract][Full Text] [Related]
12. Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.
Ousset A; Bassand C; Chavez PF; Meeus J; Robin F; Schubert MA; Somville P; Dodou K
Pharm Dev Technol; 2019 Jun; 24(5):560-574. PubMed ID: 30303440
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
Lim SM; Pang ZW; Tan HY; Shaikh M; Adinarayana G; Garg S
Drug Dev Ind Pharm; 2015; 41(11):1847-55. PubMed ID: 25721984
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
[TBL] [Abstract][Full Text] [Related]
16. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the Dependence of the Flory-Huggins Interaction Parameter on Temperature and Composition in a Drug-Polymer System.
Potter CB; Davis MT; Albadarin AB; Walker GM
Mol Pharm; 2018 Nov; 15(11):5327-5335. PubMed ID: 30259745
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions.
Deshpande TM; Shi H; Pietryka J; Hoag SW; Medek A
Mol Pharm; 2018 Mar; 15(3):962-974. PubMed ID: 29345955
[TBL] [Abstract][Full Text] [Related]
19. Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.
Piccinni P; Tian Y; McNaughton A; Fraser J; Brown S; Jones DS; Li S; Andrews GP
J Pharm Pharmacol; 2016 May; 68(5):705-20. PubMed ID: 26864155
[TBL] [Abstract][Full Text] [Related]
20. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
